ライフサイエンスコーパス: shortness of breath

1 s, headache, loss of taste and/or smell, and shortness of breath).

2 tail bone, and one woman had chest pain and shortness of breath).

3 st common symptoms are fever, dry cough, and shortness of breath.

4 sus non-systolic dysfunction presenting with shortness of breath.

5 , consistent in univariate analysis only for shortness of breath.

6 mild to moderate symptoms such as cough and shortness of breath.

7 production, airway hyperresponsiveness, and shortness of breath.

8 ocognitive impairment and dysautonomia), and shortness of breath.

9 ome recovered patients complain of continued shortness of breath.

10 s second profile was mediated by fatigue and shortness of breath.

11 differences in the incidence of wheezing or shortness of breath.

12 showed positive associations with wheeze and shortness of breath.

13 ic pulmonary infiltrates, chronic cough, and shortness of breath.

14 oms, including cough, sputum production, and shortness of breath.

15 of epigastric and midsternal chest pain with shortness of breath.

16 year-old man presents with left leg pain and shortness of breath.

17 present, then the most common complaint was shortness of breath.

18 nal pain, nausea, bilious emesis, cough, and shortness of breath.

19 des increased sputum purulence and worsening shortness of breath.

20 , wheeze, cough, tightness of the chest, and shortness of breath.

21 t of diastolic dysfunction and inappropriate shortness of breath.

22 c peptides in patients presenting with acute shortness of breath.

23 ardiac and noncardiac, presenting with acute shortness of breath.

24 and lung cells causing fever, dry cough, and shortness of breath.

25 5; p<0.1), sputum (3.15, 1.39-7.13; p<0.05), shortness of breath (1.86, 0.97-3.57; p<0.1), and wheeze

26 1.44 [95% confidence interval: 1.22, 1.70]; shortness of breath: 1.32 [1.12, 1.56]; dry cough: 1.16

27 %]), cardiac dysfunction (114 of 210 [54%]), shortness of breath (102 of 198 [52%]), and/or diarrhea

28 ords among patients with the U09.9 code were shortness of breath (130 [37.1%]), fatigue or exhaustion

29 dizziness (21%), nausea/vomiting (26%), and shortness of breath (14%).

30 (47.1%) participants, with fatigue (21.2%), shortness of breath (14.5%) and forgetfulness (9.1%) the

31 ratio 2.07 [95% CI 1.41-3.05]), waking with shortness of breath (2.32 [1.25-4.34]), and asthma attac

32 y symptoms (persistent or recurring cough or shortness of breath), 2) chronic bronchitis or emphysema

33 mplain of fatigue (54% v 20%; P = .0002) and shortness of breath (22% v 8%; P = .02).

34 s reported at 3 months were fatigue (50.3%), shortness of breath (23.4%), confusion or lack of concen

35 ness (247 [49.3%]; 95% CI, 44.9%-53.7%), and shortness of breath (232 [46.3%]; 95% CI, 41.9%-50.7%).

36 symptom was palpitation (85.7%) followed by shortness of breath (25%).

37 [77.8%] vs 39 of 40 [97.5%]; ASD, 0.63) and shortness of breath (3 of 9 [33.3%] vs 23 of 40 [57.5%];

38 th respiratory symptoms such as cough (40%), shortness of breath (34%), hemoptysis (10%), or metastas

39 s of estrogen treatment (abdominal pain 60%, shortness of breath 40%, or both 35%).

40 igue (70.7%), sleep disturbance (47.8%), and shortness of breath (42.1%).

41 ars; 63% women; 17% smokers; 77% phlegm; 70% shortness of breath; 47% wheezing; 46% chest pain; 42% a

42 The most common symptoms were cough and shortness of breath; 50% of patients had fever on admiss

43 re affected by vocal fold weakness (55%) and shortness of breath (55%), and 11% required ventilatory

44 These included cough (64%), shortness of breath (56%), and temperature elevation (33

45 The most frequent acute symptoms were shortness of breath (57.9%), weakness (54.8%), and fatig

46 m-based descriptions of chest pain (34%) and shortness of breath (6.5%) and the condition-based diagn

47 The most common presenting symptoms were shortness of breath (63.5%), fever (52.4%), and cough (4

48 44%) were asymptomatic, but 8 (44%) reported shortness of breath, 7 (39%) reported cough, and 5 (28%)

49 le and/or irritation (92.1%), cough (78.5%), shortness of breath (72.5%), and pain on deep inspiratio

50 0%), chest tightness (93%), cough (80%), and shortness of breath (73%).

51 The most common LC symptom was shortness of breath (80%), and 27% of participants were

52 r nausea, 57% for pain, 94% for appetite and shortness of breath, 87% for anxiety, 86% for depression

53 solute standardized difference [ASD], 0.30), shortness of breath (9 of 9 [100%] vs 7 of 23 [30.4%]; A

54 f LVP performed, cumulative volume from LVP, shortness of breath, abdominal distention, abdominal pai

55 imes the expected rates of chronic cough and shortness of breath, according to comparisons with the n

56 of 2020, all respiratory conditions, except shortness of breath, accounted for a smaller proportion

57 - to 1.4-fold more likely to report cough or shortness of breath and 1.8-fold more likely to report c

58 The association between shortness of breath and a 5-mug/m(3) increment in PM2.5

59 moderate to severe anxiety, depression, and shortness of breath and an increasing t-ESAS score after

60 tween prevalence of self-reported wheeze and shortness of breath and annual mean particulate matter w

61 Greater shortness of breath and beta-agonist use appears to be p

62 rgency department in December with worsening shortness of breath and chest heaviness for 1 week.

63 ed by age 5-6, and predominant symptoms were shortness of breath and chest tightness.

64 such abnormalities were more likely to have shortness of breath and chronic cough and reduced measur

65 d BV may contribute to exercise intolerance, shortness of breath and chronic fatigue, secondary to re

66 gency department of an outside hospital with shortness of breath and cough.

67 He was admitted to evaluate progressive shortness of breath and dry cough of 1-month duration.

68 Shortness of breath and fatigue were reported by virtual

69 ection, whose symptoms include fever, cough, shortness of breath and fatigue.

70 A 72-year-old man presented with progressive shortness of breath and increasing consolidation.

71 nter of UCSD Medical Center with significant shortness of breath and limitation of daily activities.

72 two adverse events of grade 2 or higher (n=1 shortness of breath and n=1 arthralgia) and none in the

73 homa is a medical condition characterised by shortness of breath and obscure chest pain, which may be

74 ss, headache and numbness), cardiopulmonary (shortness of breath and oedema), dermatological (pruritu

75 or wall myocardial infarction presented with shortness of breath and palpitations.

76 our averages) were associated with increased shortness of breath and rescue medication use.

77 resulting in right ventricular failure with shortness of breath and syncope.

78 bo, n=1), which was unrelated to study drug (shortness of breath and throat tightness after severe co

79 Early symptoms of shortness of breath and wheezing progressed over 2 wk to

80 y department of our hospital for progressive shortness of breath and worsening productive cough of 2

81 k of fatigue, sexual dysfunction, dysphagia, shortness of breath and/or hypotension, procedure-relate

82 ce of obesity, absence of diabetes mellitus, shortness of breath, and a short delay between pain onse

83 Fever, chills, cough, shortness of breath, and abdominal or chest pain were de

84 r or more weeks after infection) of fatigue, shortness of breath, and cognitive dysfunction, as well

85 ypes, characterized by symptoms of wheezing, shortness of breath, and coughing due to airway hyperrea

86 uction characterised clinically by wheezing, shortness of breath, and coughing.

87 tion, which can lead to reduced oxygenation, shortness of breath, and death.

88 soon thereafter she had a headache, nausea, shortness of breath, and dizziness.

89 ith physical symptoms, such as palpitations, shortness of breath, and dizziness.

90 ymptoms, including severity of fever, cough, shortness of breath, and fatigue (rated on a 4-point sca

91 s included headache, fever, chills, myalgia, shortness of breath, and fatigue.

92 common cluster consisted of cough, fatigue, shortness of breath, and headache and was found in 308 (

93 Age, overall presence of symptoms, shortness of breath, and hypertension were found to be k

94 During March 2020, cough, shortness of breath, and influenza-like illness accounte

95 , worse ESAS-r scores (tiredness, wellbeing, shortness of breath, and pain), PHQ-9 scores (12.5 (6, 1

96 l distention, a 5-pound weight gain, nausea, shortness of breath, and reduced urinary frequency.

97 ort severe fatigue, orthostatic intolerance, shortness of breath, and reductions in exercise toleranc

98 or taste, thirst, chronic cough, chest pain, shortness of breath, and sleep apnea.

99 iated with ED/Hosp use, with pain, appetite, shortness of breath, and tiredness demonstrating the str

100 sease (a cough, a fever of 37.8 C or higher, shortness of breath, anosmia, or ageusia).

101 Fluid retention and shortness of breath are its cardinal manifestations for

102 hite (odds ratio, 2.2; 1.1 to 4.3), reported shortness of breath as their chief symptom (odds ratio,

103 sthma (past 12 months), defined as: woken by shortness of breath, asthma attack, or asthma medication

104 versus those without lesions), particularly "shortness of breath at night" (odds ratio (OR) = 2.8, 95

105 cirrhosis presented with a 2-week history of shortness of breath at rest, orthopnea, and lower extrem

106 of 54 patients newly diagnosed with episodic shortness of breath attributed to ILO were evenly random

107 Contacts who developed fever, cough, or shortness of breath became persons under investigation a

108 rity of 6 PASC symptoms (fatigue, brain fog, shortness of breath, body aches, gastrointestinal sympto

109 rrelated with increasing fatigue, increasing shortness of breath (both, r = -0.35; P =.

110 She is somewhat limited by the shortness of breath but maintains an Eastern Cooperative

111 th poor well-being, depression, anxiety, and shortness of breath, but not with other somatic symptoms

112 Patients frequently suffer from cough, shortness of breath, chest pain and pronounced fatigue a

113 viously experienced intermittent episodes of shortness of breath, chest pain, and palpitations with e

114 isode are similar, and both can present with shortness of breath, chest pain, cough, and wheezing.

115 uded fever in 13 patients (41%) and moderate shortness of breath, chest pain, or both in six (19%).

116 ealth status, including symptoms of fatigue, shortness of breath, chest pain, physical and social lim

117 piratory symptoms (wheeze, persistent cough, shortness of breath, chest tightness).

118 ts with acute asthma will exhibit increasing shortness of breath, chest tightness, coughing, and/or w

119 Adults were often afebrile and complained of shortness of breath, chills, and severe pain.

120 % of participants experienced some degree of shortness of breath, cough, difficulty breathing, appeti

121 The patient denied chest pain, shortness of breath, cough, or recent exposure to sick i

122 ges in both patients, but angina or abnormal shortness of breath did not develop in either patient du

123 01), and limitation in desired activities by shortness of breath (difference, 2.8; 95% CI, 1.3-4.3; P

124 CI, 1.6-4.8; P < .001), sleep limitation by shortness of breath (difference, 3.0; 95% CI, 1.6-4.4; P

125 wenty-two (22%) of 98 patients complained of shortness of breath during everyday activities compared

126 -MB) and one of the following: chest pain or shortness of breath during the preceding 24 h or electro

127 the chief complaints of dyspnea on exertion, shortness of breath, dysphagia, generalized weakness, an

128 Shortness of breath, dyspnea, or respiratory distress or

129 erval 0.37-0.86), fatigue (0.75, 0.46-1.24), shortness of breath/dyspnoea (0.52, 0.28-0.93), breast s

130 (OR = 2.8, 95% CI: 1.2, 6.6) in smokers and "shortness of breath ever" (OR = 3.8, 95% CI: 0.7, 20.6)

131 lds, wheeze frequency, activity disturbance, shortness of breath, exercise-related and aeroallergen-r

132 rdiopulmonary symptoms including chest pain, shortness of breath, fatigue, and autonomic manifestatio

133 Its symptoms, including shortness of breath, fatigue, and edema, can be frighten

134 Three (shortness of breath, fear of progression, and hair probl

135 Four (coughing, shortness of breath, fear of progression, and surgery-re

136 omposed of five multi-item scales (coughing, shortness of breath, fear of progression, hair problems,

137 Humans typically exhibit fever, cough, shortness of breath, gastrointestinal issues, and breath

138 Patients with symptoms of abdominal pain and shortness of breath had significantly increased hepatic

139 Transient symptoms, such as shortness of breath, headache, and dizziness, were repor

140 characterized by similar symptoms (fatigue, shortness of breath, headache, sleep disturbance, forget

141 ood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy, and death.

142 e or probable symptoms of opioid withdrawal (shortness of breath, hot flushes, fever and pain, small

143 ver in 20 patients (87%), cough in 20 (87%), shortness of breath in 11 (48%), and gastrointestinal sy

144 linical features of MTX lung injury included shortness of breath in 27 patients (93.1%), which was pr

145 omatic, with cough reported in all patients, shortness of breath in 94%, and hemoptysis in 55%.

146 Reporting fever, cough, or shortness of breath in the last week during symptom scre

147 Reporting fever, cough, or shortness of breath in the last week during symptom scre

148 associated with the prevalence of wheeze and shortness of breath in this large study, with stronger a

149 atment was terminated prematurely because of shortness of breath in three patients in each group.

150 n unsuspected in patients with COPD, because shortness of breath is attributed to COPD.

151 The patient presented with shortness of breath, malaise, and cough that had develop

152 with each subject waking and complaining of shortness of breath (mean time to arousal, 115 s; range,

153 combinations, 5 MPM symptoms (pain, fatigue, shortness of breath, muscle weakness, coughing) were sel

154 Cough, fever, shortness of breath, myalgia, fatigue/weakness and heada

155 en characterized by hypotension, nausea, and shortness of breath occurring within 30 minutes after ad

156 verweight/obese children more often reported shortness of breath (odds ratio = 11.8; 95% CI, 1.41-98.

157 On multivariable analysis, shortness of breath (odds ratio [OR], 0.008; p = 0.072),

158 typical symptoms of covid-19 (cough, fever, shortness of breath), of whom only five were tested befo

159 ion of microwave popcorn had higher rates of shortness of breath on exertion and skin problems that h

160 symptoms, defined as any reported wheezing, shortness of breath or dry nocturnal cough, were reporte

161 symptoms occurring most frequently included shortness of breath or dyspnea (26 studies; median frequ

162 atic and denied fevers, sweats, weight loss, shortness of breath or dyspnea on exertion, or cough.

163 Slight improvement in shortness of breath or fatigue was associated with signi

164 tion defined by meeting both criteria of (1) shortness of breath or hospitalization for shortness of

165 ere most strongly influenced by the risks of shortness of breath or hypotension, fatigue, and procedu

166 ) shortness of breath or hospitalization for shortness of breath or pneumonia and (2) oxygen saturati

167 .93), anxiety (OR, 1.57; 95% CI, 1.30-1.89), shortness of breath (OR, 1.38; 95% CI, 1.16-1.61), femal

168 epression (OR, 1.66; 95% CI, 1.20-2.31), and shortness of breath (OR, 1.65; 95% CI, 1.18-2.31) and ea

169 CI, 1.3 to 2.2), attacks of wheezing causing shortness of breath (OR, 1.6; 95% CI, 1.2 to 2.1) or awa

170 % confidence interval [95% CI], 1.15, 4.47), shortness of breath (OR, 2.33; 95% CI, 1.12, 5.06), and

171 CI; 1.3 to 4.3), attacks of wheezing causing shortness of breath (OR, 2.4; 95% CI, 1.3 to 4.4) or awa

172 Fever (OR, 1.66 [95% CI, 1.41-1.96]), shortness of breath (OR, 2.52 [95% CI, 2.00-3.16]), tach

173 % confidence interval (CI): 1.11, 1.21]} and shortness of breath [OR=1.61 per 5mug/m(3) (95% CI: 1.45

174 one qualifying symptom (fever 37.8 C, cough, shortness of breath, or anosmia or ageusia) more than 14

175 f symptoms (pain, disturbed sleep, distress, shortness of breath, or constipation) reached a predeter

176 n patients presenting with acute chest pain, shortness of breath, or syncope.

177 76-year-old man consults you for increasing shortness of breath over the past two years and an incre

178 ell as male sex (P = .025), wheezing causing shortness of breath (P = .002), and ACS at less than 4 y

179 vel of asthma severity, whereas intensity of shortness of breath predicted HRQL at all levels of asth

180 change in University of California San Diego-Shortness of Breath Questionnaire (UCSD-SOBQ) score, cha

181 dyspnea (University of California, San Diego Shortness of Breath Questionnaire [UCSD SOBQ]), 6-minute

182 55] and University of California, San Diego, Shortness of Breath Questionnaire total score [r = 0.70]

183 s in the University of California, San Diego Shortness of Breath Questionnaire), health status (reduc

184 6D; the University of California, San Diego, Shortness of Breath Questionnaire; FVC; Dl(CO); and 6-mi

185 function (r=-0.87), vitality (r=-0.85), and shortness-of-breath (r=0.84) scales.

186 23, participants aged 21 years or older with shortness of breath recruited from 4 clinical sites unde

187 ry muscle function may result in symptoms of shortness of breath, reductions in vital capacity, and a

188 in the relative risks for severe wheeze with shortness of breath (relative risk 0.44 [95% CI 0.20-1.0

189 95% confidence intervals [CIs] 1.41, 2.10), shortness of breath (RR 2.60, 95% CIs 1.96, 3.44), memor

190 Health Survey questionnaire, an established shortness-of-breath scale, and the Minnesota Living with

191 Thirst was moderately intense, and shortness of breath, scared, confusion, and pain were mo

192 Some symptoms such as breathlessness and shortness of breath seem not to be evidence-based asthma

193 the emergency department with chest pain and shortness of breath shortly after a viral infection.

194 trophic Cardiomyopathy Symptom Questionnaire Shortness-of-Breath subscore (HCMSQ-SoB).

195 atic with typical symptoms (fever, cough, or shortness of breath), symptomatic with only atypical sym

196 ngeal obstruction (ILO) presents as episodic shortness of breath that can range in severity and may g

197 report a range of symptoms from headaches to shortness of breath to taste and smell loss.

198 second dose, she developed chest tightness, shortness of breath, tongue swelling, diffuse pruritic r

199 iables most predictive of CD: age, diabetes, shortness of breath, use of vasodilator stress, rest hea

200 n exposures and the prevalence of wheeze and shortness of breath using harmonized baseline data from

201 rrelation (rg) with diabetes (rg = 0.25) and shortness of breath walking on level ground (rg = 0.28)

202 An increased risk of shortness of breath was also associated with the combina

203 Shortness of breath was also more common among nonhospit

204 Shortness of breath was higher on days 7-21, with a dip

205 Shortness of breath was more common among persons with a

206 Shortness of breath was the most common presenting sympt

207 Shortness of breath was the only symptom associated with

208 trial in which patients seen in the ED with shortness of breath were consented to have BNP levels dr

209 Fatigue and shortness of breath were significantly more common in pa

210 igue, headache, fever, muscle or joint pain, shortness of breath) were the most important clinical pr

211 g, persistent coughing and mucus production, shortness of breath, wheezing, and chest tightness.

212 5-3.7) in men and 2.7 (2.3-3.1) in women for shortness of breath when walking upstairs; 4.5 (2.5-7.8)

213 He reports both mild shortness of breath with exertion and minimal chronic sw

214 c inflammatory condition defined by episodic shortness of breath with expiratory wheezing and cough,